Prognostic factors for acute myeloid leukemia patients with t(6;9)(p23;q34) who underwent an allogeneic hematopoietic stem cell transplant.
1] Department of Cellular Transplantation Biology, Kanazawa University Graduate School of Medical Sciences, Kanazawa, Ishikawa, Japan  Department of Hematology, Tokyo Metropolitan Ohtsuka Hospital, Toshima, Tokyo, Japan.Leukemia: official journal of the Leukemia Society of America, Leukemia Research Fund, U.K (impact factor: 8.3). 12/2011; 26(6):1416-9. DOI:10.1038/leu.2011.350 pp.1416-9
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed. The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual current impact factor. Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence agreement may be applicable.